"Patient Reported Outcome After Dislocation of a Primary THA"
1 other identifier
observational
4,000
1 country
1
Brief Summary
The aim is to compare QOL and hip specific outcome measures in patients with a single or recurrent episode(s) of THA dislocation and patients with a THA without any dislocation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 28, 2019
CompletedFirst Posted
Study publicly available on registry
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedMarch 1, 2019
February 1, 2019
7 months
February 28, 2019
February 28, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
QOL (Quality of life)
Measured by the EQ-5D questionnaire.
9 years
Hip function
Measured by the HOOS questionnaire.
9 years
Secondary Outcomes (1)
Activity
9 years
Study Arms (4)
Single dislocation.
Patients with a single postoperative hip dislocation without subsequent revision surgery.
Recurrent dislocation.
Patients with two or more postoperative hip dislocations without subsequent revision surgery.
Revision due to dislocation.
Patients with one or more postoperative hip dislocations with subsequent revision surgery due to recurrent instability.
Controls.
Matched patients without postoperative hip dislocation or revision of any reason.
Interventions
No intervention.
Eligibility Criteria
The patients had undergone primary surgery in the 5-year period from 01.01.2010 - 31.12.2014 and subsequent dislocation was evaluated in a 2-year follow-up period. Cases are found in a previously described study (Protocol-ID 3-3013-2128/1). 1100-1800 cases will be identified, anticipated. A matched control group of patients with primary THA without any event of dislocation are located from the original 5-year period of primary surgery. They will be matched with the group of patients with dislocation, regarding to: 1. Age (+/- 5 years) 2. Gender 3. Date of surgery and hospital
You may qualify if:
- patients with one or more events of hip dislocation after a primary THA
- controls with a primary THA without events of hip dislocation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of South West Jutland
Esbjerg, Region Syddanmark, 6700, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lars L. Hermansen, MD
Department of Clinical Research, Odense University Hospital, Odense, Denmark.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2019
First Posted
March 1, 2019
Study Start
January 1, 2019
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
March 1, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share
Data not to be shared.